Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Cem Mirili, Semra Paydaş, Isa B Guney, Ali Ogul, Serkan Gokcay, Mahmut Buyuksimsek, Abdullah E Yetisir, Bilgin Karaalioglu, Mert Tohumcuoglu & Gulsah Seydaoglu. (2019) Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study. Cancer Management and Research 11, pages 3445-3453.
Read now
Read now
Peng Luo, Weiluo Cai, Lingge Yang, Shiqi Chen, Zhiqiang Wu, Yong Chen, Ruming Zhang, Yingqiang Shi, Wangjun Yan & Chunmeng Wang. (2018) Prognostic significance of pretreatment lymphocyte/monocyte ratio in retroperitoneal liposarcoma patients after radical resection. Cancer Management and Research 10, pages 4727-4734.
Read now
Read now
Articles from other publishers (48)
Eashwar Somasundaram, Peter M. Anderson, Timothy D. Smile, Ahmed Halima, James B. Broughman, Chandana A. Reddy, Shireen Parsai, Jacob G. Scott, Timothy Chan, Shauna Campbell, Lilyana Angelov, Stacey Zahler, Matteo Trucco, Stefanie M. Thomas, Shavaughn Johnson, Peng Qi, Anthony Magnelli & Erin S. Murphy. (2023) Neutrophil to lymphocyte ratio (NTLR) predicts local control and overall survival after stereotactic body radiotherapy (SBRT) in metastatic sarcoma. Scientific Reports 13:1.
Crossref
Crossref
Tomoki Nakamura, Kunihiro Asanuma, Tomohito Hagi & Akihiro Sudo. (2023) What is a useful marker for predicting survival in patients with high-grade soft tissue sarcoma who have non-inflammatory conditions?. Journal of Orthopaedic Science.
Crossref
Crossref
Sho Watanabe, Tatsunori Shimoi, Tadaaki Nishikawa, Asuka Kawachi, Hitomi Sumiyoshi Okuma, Momoko Tokura, Shu Yazaki, Chiharu Mizoguchi, Motoko Arakaki, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Yuki Kojima, Kazuki Sudo, Emi Noguchi, Akihiko Yoshida, Akira Kawai, Yasuhiro Fujiwara & Kan Yonemori. (2023) Lymphocyte-to-monocyte ratio as a prognostic and potential tumor microenvironment indicator in advanced soft tissue sarcoma treated with first-line doxorubicin therapy. Scientific Reports 13:1.
Crossref
Crossref
Qiuji Wu, Juan Wang, Shaojie Li, Jia Liu, Yanshuang Cheng, Jieying Jin & Yahua Zhong. (2023) Comparison of Definitive Radiotherapy-Based Treatment and Surgical-Based Treatment for Locally Advanced Head and Neck Soft Tissue Sarcoma. Journal of Clinical Medicine 12:9, pages 3099.
Crossref
Crossref
Valentina Fausti, Alessandro De Vita, Silvia Vanni, Virginia Ghini, Lorena Gurrieri, Nada Riva, Roberto Casadei, Marco Maraldi, Giorgio Ercolani, Davide Cavaliere, Carlo Alberto Pacilio, Federica Pieri, Flavia Foca, Alberto Bongiovanni, Nicoletta Ranallo, Sebastiano Calpona, Giovanni Luca Frassineti, Toni Ibrahim & Laura Mercatali. (2023) Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and Trabectedin. Cancers 15:4, pages 1080.
Crossref
Crossref
Marco Fiore, Silva Ljevar, Sandro Pasquali, Daniele Morelli, Dario Callegaro, Roberta Sanfilippo, Marta Barisella, Claudia Sangalli, Rosalba Miceli & Alessandro Gronchi. (2023) Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study. Clinical Cancer Research 29:3, pages 614-620.
Crossref
Crossref
Keith M. Skubitz, Evidio Domingo-Musibay, Bruce R. Lindgren & Edward Y. Cheng. (2022) Prospective Trial of Neutrophil/Lymphocyte Ratio and Other Blood Counts as Biomarkers of Survival among Patients with High-Grade Soft Tissue Sarcomas Treated with Pegylated Liposomal Doxorubicin and Ifosfamide. Cancers 14:14, pages 3419.
Crossref
Crossref
Dorian Yarih García-Ortega, Ana Paulina Melendez-Fernandez, Alethia Alvarez-Cano, Miguel Angel Clara-Altamirano, Claudia Caro-Sanchez, Gabriela Alamilla-Garcia & Kuauhyama Luna-Ortiz. (2022) Neutrophil-to-Lymphocyte ratio as a prognostic biomarker in extremities undifferentiated pleomorphic sarcoma. Surgical Oncology 42, pages 101746.
Crossref
Crossref
Dorian Yarih Garcia-Ortega, David Ponce-Herrera, Alethia Alvarez-Cano, Claudia Caro-Sanchez & Kuauhyama Luna-Ortiz. (2022) Preoperative neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) as prognostic markers in patients with retroperitoneal liposarcoma. Surgery in Practice and Science 9, pages 100076.
Crossref
Crossref
Yoshiyuki Matsui, Ayumu Matsuda, Aiko Maejima, Yasuo Shinoda, Eijiro Nakamura, Motokiyo Komiyama & Hiroyuki Fujimoto. (2022) The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma. International Journal of Clinical Oncology 27:6, pages 1093-1100.
Crossref
Crossref
Taketsugu Fujibuchi, Hiroshi Imai, Teruki Kidani, Tadao Morino & Hiromasa Miura. (2022) Serum lactate dehydrogenase levels predict the prognosis of patients with soft tissue sarcoma. Molecular and Clinical Oncology 16:3.
Crossref
Crossref
信彦 横山, 良平 横山 & 昌人 吉本. (2021) 深層発生脂肪腫と異型脂肪腫様腫瘍の鑑別における炎症性マーカーの有用性. Orthopedics & Traumatology 70:4, pages 754-757.
Crossref
Crossref
Lavinia E. Chiti, Roberta Ferrari, Patrizia Boracchi, Emanuela Morello, Laura Marconato, Paola Roccabianca, Giancarlo Avallone, Selina Iussich, Alessia Giordano, Erica I. Ferraris, Chiara Agnoli, Francesco Dondi, Davide Giacobino, Francesco Godizzi & Damiano Stefanello. (2021) Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumours. Veterinary and Comparative Oncology 19:2, pages 275-283.
Crossref
Crossref
D. Viñal, D. Martinez, J. A. Garcia-Cuesta, L. Gutierrez-Sainz, S. Martinez-Recio, J. Villamayor, V. Martinez-Marin, A. Gallego, E. Ortiz-Cruz, M. Mendiola, J. J. Pozo-Kreilinger, A. Berjon, B. Belinchon, D. Bernabeu, E. Espinosa, J. Feliu & A. Redondo. (2020) Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas. Clinical and Translational Oncology 22:10, pages 1849-1856.
Crossref
Crossref
Ferdiansyah Mahyudin, Mouli Edward, Muhammad Hardian Basuki, Yunus Basrewan, Kukuh Dwiputra Hernugrahanto & Adhinanda Gema Wahyudiputra. (2020) Analysis of prognostic factors in soft tissue sarcoma: Cancer registry from a single tertiary hospital in Indonesia. A retrospective cohort study. Annals of Medicine and Surgery 57, pages 257-263.
Crossref
Crossref
Patrick B. Schwartz, George Poultsides, Kevin Roggin, John H. Howard, Ryan C. Fields, Callisia N. Clarke, Konstantinos Votanopoulos, Kenneth Cardona & Emily R. Winslow. (2020) PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. Journal of Surgical Research 251, pages 228-238.
Crossref
Crossref
Long-Qing Li, Zhen-Hua Bai, Liang-Hao Zhang, Yan Zhang, Xin-Chang Lu, Yi Zhang, Yong-Kui Liu, Jia Wen & Jia-Zhen Li. (2020) Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis. Frontiers in Oncology 10.
Crossref
Crossref
Geumju Park, Si Yeol Song, Jin-Hee Ahn, Wan-lim Kim, Jong-seok Lee, Seong-Yun Jeong, Jae Won Park, Eun Kyung Choi, Wonsik Choi & In-Hye Jung. (2019) The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiation Oncology 14:1.
Crossref
Crossref
Breelyn A. Wilky. (2019) Immune checkpoint inhibitors: The linchpins of modern immunotherapy. Immunological Reviews 290:1, pages 6-23.
Crossref
Crossref
Breelyn A Wilky, Matteo M Trucco, Ty K Subhawong, Vaia Florou, Wungki Park, Deukwoo Kwon, Eric D Wieder, Despina Kolonias, Andrew E Rosenberg, Darcy A Kerr, Efrosyni Sfakianaki, Mark Foley, Jaime R Merchan, Krishna V Komanduri & Jonathan C Trent. (2019) Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial. The Lancet Oncology 20:6, pages 837-848.
Crossref
Crossref
Soon Teck Seo, Vivek Ajit Singh & Nor Faissal Yasin. (2019) Preoperative lymphocyte count in relation to sarcoma prognosis. Journal of Orthopaedic Surgery 27:2, pages 230949901985495.
Crossref
Crossref
Gang Liu, Li-chi Ke & Sheng-rong Sun. (2018) Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in patients with soft tissue sarcoma. Medicine 97:36, pages e12176.
Crossref
Crossref
Jason Yongsheng Chan, Zewen Zhang, Winston Chew, Grace Fangmin Tan, Chloe Liwen Lim, Lingyue Zhou, Wei Lin Goh, Eileen Poon, Nagavalli Somasundaram, Sathiyamoorthy Selvarajan, Kesavan Sittampalam, Francis Chin, Jonathan Teh, Mann Hong Tan, Khee Chee Soo, Melissa Teo, Mohamad Farid & Richard Quek. (2018) Biological significance and prognostic relevance of peripheral blood neutrophil-to-lymphocyte ratio in soft tissue sarcoma. Scientific Reports 8:1.
Crossref
Crossref
Ross D. Dolan, Jason Lim, Stephen T. McSorley, Paul G. Horgan & Donald C. McMillan. (2017) The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis. Scientific Reports 7:1.
Crossref
Crossref
Katja Maretty-Kongstad, Ninna Aggerholm-Pedersen, Johnny Keller & Akmal Safwat. (2017) A Validated Prognostic Biomarker Score for Adult Patients with Nonmetastatic Soft Tissue Sarcomas of the Trunk and Extremities. Translational Oncology 10:6, pages 942-948.
Crossref
Crossref
Shiming Shi, Qing Chen, Luxi Ye, Dan Yin, Xuedong Li, Zhi Dai & Jian He. (2017) Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy. Oncotarget 8:45, pages 79366-79375.
Crossref
Crossref
Agnish Nayak, Dermot T. McDowell, Stewart J. Kellie & Jonathan Karpelowsky. (2017) Elevated Preoperative Neutrophil–Lymphocyte Ratio is Predictive of a Poorer Prognosis for Pediatric Patients with Solid Tumors. Annals of Surgical Oncology 24:11, pages 3456-3462.
Crossref
Crossref
Tomoki Nakamura, Akihiko Matsumine, Takao Matsubara, Kunihiro Asanuma, Yuki Yada, Tomohito Hagi & Akihiro Sudo. (2017) Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma. PLOS ONE 12:7, pages e0181787.
Crossref
Crossref
Peter M. Anderson. 2017. Immunotherapy. Immunotherapy
127
140
.
Yanyan Li, Xiaoxiao Liu, Jing Zhang & Weiqiang Yao. (2016) Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma. Cancer Biomarkers 16:3, pages 333-342.
Crossref
Crossref
L. Macfarlane, J. Morris, K. Pratschke, D. Mellor, T. Scase, M. Macfarlane & G. Mclauchlan. (2016) Diagnostic value of neutrophil-lymphocyte and albumin-globulin ratios in canine soft tissue sarcoma. Journal of Small Animal Practice 57:3, pages 135-141.
Crossref
Crossref
Xiu-Ping Tu, Qian-Hui Qiu, Liang-Si Chen, Xiao-Ning Luo, Zhong-Ming Lu, Si-Yi Zhang & Shao-Hua Chen. (2015) Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma. BMC Cancer 15:1.
Crossref
Crossref
Yi Que, Haibo Qiu, Yuanfang Li, Yongming Chen, Wei Xiao, Zhiwei Zhou & Xing Zhang. (2015) Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma. BMC Cancer 15:1.
Crossref
Crossref
Joanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, Michael Stotz, Hellmut Samonigg, Joerg Friesenbichler, Tatjana Stojakovic, Andreas Leithner & Martin Pichler. (2015) The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients. The American Journal of Surgery 210:1, pages 111-116.
Crossref
Crossref
T. NakamuraA. MatsumineK. AsanumaT. MatsubaraA. Sudo. (2015) The value of the high-sensitivity modified Glasgow prognostic score in predicting the survival of patients with a soft-tissue sarcoma. The Bone & Joint Journal 97-B:6, pages 847-852.
Crossref
Crossref
W. D. Harrison & C. R. Chandrasekar. (2015) Stewart–Treves syndrome following idiopathic leg lymphoedema: remember sarcoma. Journal of Wound Care 24:Sup6, pages S5-S7.
Crossref
Crossref
Yukihiro Iso, Takatsugu Matsumoto, Yuki Sakuraoka, Takayuki Shiraki, Masato Kato, Mitsugi Shimoda, Taku Aoki & Keiichi Kubota. (2015) Preoperative Neutrophil-to-Lymphocyte Ratio for Prognostication of Patients with Distal Bile Duct Carcinomas Undergoing Surgery. Digestive Surgery 32:2, pages 142-149.
Crossref
Crossref
Sally Temraz, Deborah Mukherji, Zein Al Abideen Farhat, Rami Nasr, Maya Charafeddine, Mohammed Shahait, Mohammad Rachad Wehbe, Rami Abou Ghaida, Ibrahim Abu Gheida & Ali Shamseddine. (2014) Preoperative lymphocyte-to-monocyte ratio predicts clinical outcome in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder: a retrospective analysis. BMC Urology 14:1.
Crossref
Crossref
Rauf Oguzhan Kum, Muge Ozcan, Deniz Baklaci, Nurcan Yurtsever Kum, Yavuz Fuat Yilmaz, Volkan Gungor & Adnan Unal. (2014) Elevated Neutrophil-to-Lymphocyte Ratio in Squamous Cell Carcinoma of Larynx Compared to Benign and Precancerous Laryngeal Lesions. Asian Pacific Journal of Cancer Prevention 15:17, pages 7351-7355.
Crossref
Crossref
Ju-Yeon Kim, Taejin Park, Sang-Ho Jeong, Chi-Young Jeong, Young-Tae Ju, Young-Joon Lee, Soon-Chan Hong, Woo-Song Ha, Sang-Kyung Choi & Eun Jung Jung. (2013) Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 46:3, pages 526-531.
Crossref
Crossref
Joanna Szkandera, Armin Gerger, Bernadette Liegl-Atzwanger, Gudrun Absenger, Michael Stotz, Joerg Friesenbichler, Slave Trajanoski, Tatjana Stojakovic, Katharina Eberhard, Andreas Leithner & Martin Pichler. (2014) The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. International Journal of Cancer 135:2, pages 362-370.
Crossref
Crossref
Arnoud J. Templeton, Mairéad G. McNamara, Boštjan Šeruga, Francisco E. Vera-Badillo, Priya Aneja, Alberto Ocaña, Raya Leibowitz-Amit, Guru Sonpavde, Jennifer J. Knox, Ben Tran, Ian F. Tannock & Eitan Amir. (2014) Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis. JNCI: Journal of the National Cancer Institute 106:6.
Crossref
Crossref
Eun-Seok Choi, Han-Soo Kim & Ilkyu Han. (2013) Elevated Preoperative Systemic Inflammatory Markers Predict Poor Outcome in Localized Soft Tissue Sarcoma. Annals of Surgical Oncology 21:3, pages 778-785.
Crossref
Crossref
M Stotz, M Pichler, G Absenger, J Szkandera, F Arminger, R Schaberl-Moser, H Samonigg, T Stojakovic & A Gerger. (2013) The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. British Journal of Cancer 110:2, pages 435-440.
Crossref
Crossref
Shun-Jun Fu, Shun-Li Shen, Shao-Qiang Li, Yun-Peng Hua, Wen-Jie Hu, Li-Jian Liang & Bao-Gang Peng. (2013) Prognostic value of preoperative peripheral neutrophil-to-lymphocyte ratio in patients with HBV-associated hepatocellular carcinoma after radical hepatectomy. Medical Oncology 30:4.
Crossref
Crossref
Tomoki Nakamura, Akihiko Matsumine, Takao Matsubara, Kunihiro Asanuma, Astumasa Uchida & Akihiro Sudo. (2013) The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. Journal of Surgical Oncology 108:7, pages 481-485.
Crossref
Crossref
Graeme J.K. Guthrie, Kellie A. Charles, Campbell S.D. Roxburgh, Paul G. Horgan, Donald C. McMillan & Stephen J. Clarke. (2013) The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer. Critical Reviews in Oncology/Hematology 88:1, pages 218-230.
Crossref
Crossref
J Szkandera, G Absenger, B Liegl-Atzwanger, M Pichler, M Stotz, H Samonigg, M Glehr, M Zacherl, T Stojakovic, A Gerger & A Leithner. (2013) Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. British Journal of Cancer 108:8, pages 1677-1683.
Crossref
Crossref